132 related articles for article (PubMed ID: 1604043)
21. Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol.
Yong CS; Yang CH; Rhee JD; Lee BJ; Kim DC; Kim DD; Kim CK; Choi JS; Choi HG
Int J Pharm; 2004 Jan; 269(1):169-76. PubMed ID: 14698588
[TBL] [Abstract][Full Text] [Related]
22. Comparative bioavailability study of two oral formulations of ibuprofen.
Corpetti G; Rosignoli MT; Dionisio P
Arzneimittelforschung; 1998 Apr; 48(4):392-5. PubMed ID: 9608882
[TBL] [Abstract][Full Text] [Related]
23. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
Chen M; Xu D; Hu XL; Wang H
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
[TBL] [Abstract][Full Text] [Related]
24. Plasma concentrations following single doses of morphine sulfate in oral solution and rectal suppository.
Ellison NM; Lewis GO
Clin Pharm; 1984; 3(6):614-7. PubMed ID: 6548939
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of ibuprofen after intravenous and oral administration and assessment of safety of administration to healthy foals.
Breuhaus BA; DeGraves FJ; Honore EK; Papich MG
Am J Vet Res; 1999 Sep; 60(9):1066-73. PubMed ID: 10490073
[TBL] [Abstract][Full Text] [Related]
26. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188.
Newa M; Bhandari KH; Li DX; Kwon TH; Kim JA; Yoo BK; Woo JS; Lyoo WS; Yong CS; Choi HG
Int J Pharm; 2007 Oct; 343(1-2):228-37. PubMed ID: 17597315
[TBL] [Abstract][Full Text] [Related]
27. Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats.
Choi JS; Shin SC
Int J Pharm; 2005 Mar; 292(1-2):149-56. PubMed ID: 15725561
[TBL] [Abstract][Full Text] [Related]
28. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
[TBL] [Abstract][Full Text] [Related]
29. Influence of the hydrophilicity of suppository bases on rectal absorption of carprofen, a lipophilic nonsteroidal anti-inflammatory drug.
Schmitt M; Guentert TW
J Pharm Sci; 1990 Apr; 79(4):359-63. PubMed ID: 2352151
[TBL] [Abstract][Full Text] [Related]
30. Bioavailability of two ibuprofen oral paste formulations in fed or nonfed ponies.
Vandenbossche GM; Bouckaert S; De Muynck C; Mommens G; Van Zeveren A; Remon JP
Am J Vet Res; 1992 Apr; 53(4):528-31. PubMed ID: 1586023
[TBL] [Abstract][Full Text] [Related]
31. Improvement by adjuvants on the rectal bioavailability of non-absorbable drugs following administration of suppository.
Nakanishi K; Masada M; Nadai T
J Pharmacobiodyn; 1990 Dec; 13(12):760-5. PubMed ID: 2098548
[TBL] [Abstract][Full Text] [Related]
32. Biopharmaceutical evaluation of ketoprofen following intravenous, oral, and rectal administration in dogs.
Schmitt M; Guentert TW
J Pharm Sci; 1990 Jul; 79(7):614-6. PubMed ID: 2398469
[TBL] [Abstract][Full Text] [Related]
33. Characterization of organogel as a novel oral controlled release formulation for lipophilic compounds.
Iwanaga K; Sumizawa T; Miyazaki M; Kakemi M
Int J Pharm; 2010 Mar; 388(1-2):123-8. PubMed ID: 20045041
[TBL] [Abstract][Full Text] [Related]
34. Pharmaceutical evaluation of carbamazepine suppositories in rats.
Shinoda M; Akita M; Hasegawa M; Nadai M; Hasegawa T; Nabeshima T
Biol Pharm Bull; 1995 Sep; 18(9):1289-91. PubMed ID: 8845826
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of RK-28 (a new radiosensitizer) and pharmaceutical design of a suppository form using rats.
Kim NS; Umejima H; Miyata K; Okubo M; Goto S; Kato T; Mikami Y; Sagitani H; Inoue H
Biol Pharm Bull; 1994 Jan; 17(1):106-11. PubMed ID: 8148796
[TBL] [Abstract][Full Text] [Related]
36. Bioavailability of acetaminophen suppositories.
Feldman S
Am J Hosp Pharm; 1975 Nov; 32(11):1173-5. PubMed ID: 1190239
[TBL] [Abstract][Full Text] [Related]
37. Rectal Administration of Ibuprofen: Comparison of Enema and Suppository Form.
Prasaja B; Harahap Y; Sandra M; Iskandar I; Lusthom W; Cahyaningsih P
Drug Res (Stuttg); 2022 Jan; 72(1):18-22. PubMed ID: 34416778
[TBL] [Abstract][Full Text] [Related]
38. Difference in rectal absorption of morphine from hollow-type and conventional suppositories in rabbits.
Matsumoto Y; Watanabe Y; Yamamoto I; Matsumoto M
Biol Pharm Bull; 1993 Feb; 16(2):150-3. PubMed ID: 8364450
[TBL] [Abstract][Full Text] [Related]
39. Ketoprofen suppository dosage forms: in vitro release and in vivo absorption studies in rabbits.
Babar A; Bellete T; Plakogiannis FM
Drug Dev Ind Pharm; 1999 Feb; 25(2):241-5. PubMed ID: 10065359
[TBL] [Abstract][Full Text] [Related]
40. Bioavailability and platelet aggregation inhibitory activity of solufenum. A comparison with ibuprofen.
Latini R; Villa S; Gerna M; Tognoni G; de Gaetano G
Int J Clin Pharmacol Biopharm; 1977 Oct; 15(10):492-5. PubMed ID: 924705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
